BeOne Medicines (BeiGene)

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 approved
4 in Phase 3
Next date
Sonrotoclax, Phase 1/2 trial completes
Drugs
31
in active trials · 59 in all
Trials
68 active
187 since 2021

Drugs31

DrugHow it worksPartnerStageNext dateDetails
—
Approved Nov 2026soonPhase 1/2 trial completes
PD-1 antibody
Approved Nov 2026soonPhase 2 trial completes
Kinase inhibitor
Approved Nov 2026soonPhase 2 trial completes
PARP inhibitor
Approved in China —
—
Phase 3 31 Mar 2027Phase 1/2 trial completes
—
Phase 3 Mar 2027Phase 1/2 trial completes
—
Phase 3 Apr 2029Phase 3 trial completes
—
Phase 3 30 Nov 2029Phase 3 trial completes
Artificial immunoglobulin
Phase 1/2 —
Unmodified immunoglobulin
Phase 1/2 —
—
Phase 1 31 Dec 2026Phase 1 trial completes
—
Phase 1 1 Jul 2027Phase 1 trial completes
—
Phase 1 30 Jul 2027Phase 1 trial completes
BON-107not checked
—
Phase 1 11 Oct 2027Phase 1 trial completes
—
Phase 1 1 Nov 2027Phase 1 trial completes
—
Phase 1 29 Apr 2028Phase 1 trial completes
—
Phase 1 23 Jul 2028Phase 1 trial completes
—
Phase 1 8 Aug 2028Phase 1 trial completes
—
Phase 1 29 Aug 2028Phase 1 trial completes
—
Phase 1 31 Aug 2028Phase 1 trial completes

See all 31 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

About

No active trial
28 other drugs
SEC filings
None: it does not file with the US SEC
Registry names
3 names in ClinicalTrials.gov
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow BeOne Medicines (BeiGene)

Following is part of Solo: you see every change to BeOne Medicines (BeiGene) the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in